These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6548020)

  • 1. Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cells.
    Hoshino M; Yanaihara C; Ogino K; Iguchi K; Sato H; Suzuki T; Yanaihara N
    Peptides; 1984; 5(2):155-60. PubMed ID: 6548020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical study on PHI/PHM with use of synthetic peptides.
    Yanaihara N; Yanaihara C; Nokihara K; Iguchi K; Fukata S; Tanaka M; Yamamoto Y; Mochizuki T
    Peptides; 1984; 5(2):247-54. PubMed ID: 6548021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for common precursors but differential processing of VIP and PHM in VIP-producing tumors.
    Fahrenkrug J
    Peptides; 1985; 6(3):357-61. PubMed ID: 3840886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.
    Yamagami T; Ohsawa K; Nishizawa M; Inoue C; Gotoh E; Yanaihara N; Yamamoto H; Okamoto H
    Ann N Y Acad Sci; 1988; 527():87-102. PubMed ID: 2839091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
    Mikkelsen JD; Fahrenkrug J
    Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two pro-VIP forms in a human neuroblastoma cell line.
    Svoboda M; Gregoire A; Yanaihara C; Yanaihara N; Christophe J
    Peptides; 1986; 7 Suppl 1():7-15. PubMed ID: 3018704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP regulation of pro-vasoactive intestinal polypeptide/PHM-27 synthesis in human neuroblastoma cells.
    Hayakawa Y; Obata K; Itoh N; Yanaihara N; Okamoto H
    J Biol Chem; 1984 Jul; 259(14):9207-11. PubMed ID: 6086627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and regional distribution of peptides derived from the vasoactive intestinal peptide precursor in the normal human brain.
    Fahrenkrug J; Emson PC
    J Neurochem; 1989 Oct; 53(4):1142-8. PubMed ID: 2769258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, plasma concentration, and in vivo prolactin-releasing activity of peptide histidine methionine in humans.
    Sasaki A; Sato S; Go MG; Shimizu Y; Murakami O; Hanew K; Yumita S; Andoh N; Sasano N; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Oct; 65(4):683-8. PubMed ID: 3654914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide histidine methionine and vasoactive intestinal peptide: occurrence and relaxant effect in the human female reproductive tract.
    Palle C; Ottesen B; Jørgensen J; Fahrenkrug J
    Biol Reprod; 1989 Dec; 41(6):1103-11. PubMed ID: 2624870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, specific binding sites and presence in secretions.
    Eedy DJ; Shaw C; Armstrong EP; Johnston CF; Buchanan KD
    Br J Dermatol; 1990 Jul; 123(1):65-76. PubMed ID: 2390496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects.
    Holst JJ; Fahrenkrug J; Knuhtsen S; Jensen SL; Nielsen OV; Lundberg JM; Hökfelt T
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G182-9. PubMed ID: 3548423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodinated derivatives of vasoactive intestinal peptide (VIP), PHI and PHM: purification, chemical characterization and biological activity.
    McMaster D; Suzuki Y; Rorstad O; Lederis K
    Peptides; 1987; 8(4):663-76. PubMed ID: 3628082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
    Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
    J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel prepro VIP derived peptide.
    Yiangou Y; Requejo F; Polak JM; Bloom SR
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1142-9. PubMed ID: 3767995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of PHM, PHI and 24-glutamine PHI with human VIP receptors from colonic epithelium: comparison with rat intestinal receptors.
    Laburthe M; Couvineau A; Rouyer-Fessard C; Moroder L
    Life Sci; 1985 Mar; 36(10):991-5. PubMed ID: 2983161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide histidine methionine and vasoactive intestinal peptide levels in human cerebrospinal fluid: age-related changes and absence of a correlation with serum prolactin.
    Yasuda M; Minamitani N; Maeda K; Chihara K; Fujita K; Kobayashi I
    Regul Pept; 1993 Jul; 46(3):565-73. PubMed ID: 8210516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27.
    Itoh N; Obata K; Yanaihara N; Okamoto H
    Nature; 1983 Aug 11-17; 304(5926):547-9. PubMed ID: 6571696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man.
    Fahrenkrug J; Pedersen JH; Yamashita Y; Ottesen B; Hökfelt T; Lundberg JM
    Regul Pept; 1987 Jul; 18(1):51-61. PubMed ID: 3306816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.
    Hökfelt T; Fahrenkrug J; Ju G; Ceccatelli S; Tsuruo Y; Meister B; Mutt V; Rundgren M; Brodin E; Terenius L
    Neuroscience; 1987 Dec; 23(3):827-57. PubMed ID: 3125490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.